Literature DB >> 18092245

Prevention of Alzheimer's disease.

C A Szekely1, J C S Breitner, P P Zandi.   

Abstract

The already considerable public health burden of Alzheimer's disease will likely worsen as populations around the world age. As a result, there is considerable motivation to develop effective strategies for preventing the disease. A wide variety of such strategies are under investigation and include pharmaceuticals, nutriceuticals, diet, physical activity and cognitive activity. We review here the most promising candidates and the epidemiologic evidence for their efficacy. Although none of these have yet to be definitively shown to prevent Alzheimer's disease, further research should help to clarify what role they may play in reducing the burden of this disease.

Entities:  

Mesh:

Year:  2007        PMID: 18092245     DOI: 10.1080/09540260701797944

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  11 in total

1.  Suppressed microglial E prostanoid receptor 1 signaling selectively reduces tumor necrosis factor alpha and interleukin 6 secretion from toll-like receptor 3 activation.

Authors:  Xianwu Li; Eiron Cudaback; C Dirk Keene; Richard M Breyer; Thomas J Montine
Journal:  Glia       Date:  2011-01-06       Impact factor: 7.452

Review 2.  Insulin resistance in Alzheimer's disease.

Authors:  Kelly T Dineley; Jordan B Jahrling; Larry Denner
Journal:  Neurobiol Dis       Date:  2014-09-16       Impact factor: 5.996

Review 3.  Protein phosphatases and Alzheimer's disease.

Authors:  Steven P Braithwaite; Jeffry B Stock; Paul J Lombroso; Angus C Nairn
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 4.  Antagonism of neuronal prostaglandin E(2) receptor subtype 1 mitigates amyloid β neurotoxicity in vitro.

Authors:  Xianwu Li; Shannon E Rose; Kathleen S Montine; C Dirk Keene; Thomas J Montine
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-21       Impact factor: 4.147

Review 5.  Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions.

Authors:  Jordan B Jahrling; Remi-Martin Laberge
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

6.  A Comparison of the Knowledge of Alzheimer's Disease among Community Pharmacists Based on Regional Practice Setting Using the Alzheimer's Disease Knowledge Scale (ADKS).

Authors:  Jenna Stearns; Rachel Burgoon; Zachary Sahadak; Beka Alazar; Marty L Eng
Journal:  Innov Pharm       Date:  2021-06-10

7.  Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT.

Authors:  Thomas J Montine; Joshua A Sonnen; Ginger Milne; Laura D Baker; John C S Breitner
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

Review 8.  Late onset Alzheimer's disease in older people.

Authors:  Ahmet Turan Isik
Journal:  Clin Interv Aging       Date:  2010-10-11       Impact factor: 4.458

Review 9.  Impact of social relationships on Alzheimer's memory impairment: mechanistic studies.

Authors:  Ya-Hsin Hsiao; Chih-Hua Chang; Po-Wu Gean
Journal:  J Biomed Sci       Date:  2018-01-11       Impact factor: 8.410

10.  Dietary patterns associated with Alzheimer's disease: population based study.

Authors:  Katarzyna Gustaw-Rothenberg
Journal:  Int J Environ Res Public Health       Date:  2009-04-01       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.